Mazzoni, A <br/><br/>
CD3-CD28 costimulation as a means to avoiding T cell preactivation in bispecific monoclonal antibody-based treatment of ovarian carcinoma.  [electronic resource] 

 -  Cancer research  Dec 1996 
 - 5443-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0008-5472 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Bispecific--immunology<br/>Antibodies, Monoclonal--immunology<br/>Antibody Specificity<br/>CD28 Antigens--immunology<br/>CD3 Complex--immunology<br/>Carcinoma, Squamous Cell--immunology<br/>Carrier Proteins--immunology<br/>Coculture Techniques<br/>Female<br/>Folate Receptors, GPI-Anchored<br/>Humans<br/>Immunotherapy, Adoptive--methods<br/>Lymphocyte Activation<br/>Lymphokines--metabolism<br/>Neoplasm Proteins--immunology<br/>Neoplasm, Residual<br/>Ovarian Neoplasms--immunology<br/>Receptor-CD3 Complex, Antigen, T-Cell--immunology<br/>Receptors, Cell Surface<br/>T-Lymphocyte Subsets--immunology<br/>Tumor Cells, Cultured